Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

Inclusion Criteria: * Patient with Melanoma, Non-Small Cell Bronchial Cancer, renal cell carcinoma, Ca carcinomas of the upper airways to be treated with ICI * Patient who has never received treatment by ICI * Informed patient who signed his consent * Age \> or = 18 years * Social insurance Exclusion Criteria: * Patient receiving corticosteroid or immunosuppressant 14 days before inclusion * Immunocompromised patient * Uncontrolled brain metastases * Refusal to participate, patient protected by guardianship * Patient unable to understand the study or unable to follow the education sessions